Clinical Trial: Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics of Single and Multiple Doses of HCXT-2001 Tablets in Healthy Adult Subjects, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics of Single and Multiple Doses of HCXT-2001 Tablets in Healthy Adult Subjects, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129420

Registration Time: 2026/08/04

Type: Interventional study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330540

Published by HT Digital Content Services with permission from Health Daily Diges...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics of Single and Multiple Doses of HCXT-2001 Tablets in Healthy Adult Subjects, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (China)